Genomic Testing in Colorectal Cancer: How Much Is Enough?
Published: | Updated:
The identification and characterization of gene signatures, driver events, and pharmacogenomics in molecularly homogeneous subsets of patients is likely to advance effective drug development strategies in colorectal cancer.